North America Sleep Aids Market 2021-2031 by Product Type (Smart Bedding, Lab Services, Sleep Apnea Devices, Medication, Wearable Devices, Others), Indication

North America Sleep Aids market is projected to grow by 5.5% annually in the forecast period and reach $53,183.0 million by 2031, driven by the rising geriatric population and increasing incidences of sleep disorders, the increase in awareness about sleep disorders, the advancement of novel sleep aid products, a number of government initiatives to improve public healthcare, the increasing number of healthcare facilities, and the growing usage of portable and wearable sleep apnea devices.

Highlighted with 22 tables and 48 figures, this 109-page report “North America Sleep Aids Market 2021-2031 by Product Type (Smart Bedding, Lab Services, Sleep Apnea Devices, Medication, Wearable Devices, Others), Indication (Insomnia, Sleep Apnea, Narcolepsy, Restless Leg Syndrome, REM Sleep Behavior Disorder, Sleepwalking, Others), Distribution Channel (Drug Stores, E-Commerce, Hospital Pharmacies, Retail Pharmacies), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America Sleep Aids market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

 

In-depth qualitative analyses include identification and investigation of the following aspects:

• Market Structure 

• Growth Drivers 

• Restraints and Challenges

• Emerging Product Trends & Market Opportunities

• Porter’s Fiver Forces

The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify North America Sleep Aids market in every aspect of the classification from perspectives of Product Type, Indication, Distribution Channel, and Country. 

 

Based on Product Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. 

• Smart Bedding

• Sleep Lab Services

• Sleep Apnea Devices

o Adaptive Servo-Ventilators (ASVs)

o Positive Airway Pressure (PAP) Devices

o Oral Appliances

o Facial Interfaces

o Other Sleep Apnea Devices

• Medication

o Prescription Drugs

o OTC Drugs

o Herbal Drugs

• Wearable Devices

• Other Product Types

 

Based on Indication, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. 

• Insomnia

• Sleep Apnea

• Narcolepsy

• Restless Leg Syndrome

• REM Sleep Behavior Disorder

• Sleepwalking

• Other Indications

 

By Distribution Channel, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. 

• Drug Stores

• E-Commerce

• Hospital Pharmacies

• Retail Pharmacies

 

Geographically, the following national/local markets are fully investigated:

• U.S.

• Canada

• Mexico 

For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Product Type, Indication and Distribution Channel over the forecast years are also included.

 

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players: 

Advanced Brain Monitoring Inc.

Apex Medical Corp.

Apnea Sciences Corporation

BMC Medical Co., Ltd.

Braebon Medical Corp.

Cadwell Industries Inc.

Cleveland Medical Devices Inc.

Compumedics Limited

Drive DeVilbiss Healthcare Inc.

Fisher & Paykel Healthcare Corp. Ltd.

GlaxoSmithKline plc

Itamer Medical Ltd.

Koninklijke Philips N. V.

Merck & Co., Inc.

Natus Medical Inc.

Nihon Kohden Corporation

Pfizer Inc.

ResMed Inc.

Sanofi S. A.

Sleep Number Corporation

SleepMed Inc.

SomnoMed Inc.

Teva Pharmaceutical Industries Ltd. 

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

 

1 Introduction 7

1.1 Industry Definition and Research Scope 7

1.1.1 Industry Definition 7

1.1.2 Research Scope 8

1.2 Research Methodology 11

1.2.1 Overview of Market Research Methodology 11

1.2.2 Market Assumption 12

1.2.3 Secondary Data 12

1.2.4 Primary Data 12

1.2.5 Data Filtration and Model Design 13

1.2.6 Market Size/Share Estimation 14

1.2.7 Research Limitations 15

1.3 Executive Summary 16

2 Market Overview and Dynamics 18

2.1 Market Size and Forecast 18

2.1.1 Impact of COVID-19 on World Economy 19

2.1.2 Impact of COVID-19 on the Market 21

2.2 Major Growth Drivers 23

2.3 Market Restraints and Challenges 28

2.4 Emerging Opportunities and Market Trends 31

2.5 Porter’s Fiver Forces Analysis 35

3 Segmentation of North America Market by Product Type 39

3.1 Market Overview by Product Type 39

3.2 Smart Bedding 41

3.3 Sleep Lab Services 42

3.4 Sleep Apnea Devices 43

3.4.1 Adaptive Servo-Ventilators (ASVs) 45

3.4.2 Positive Airway Pressure (PAP) Devices 46

3.4.3 Oral Appliances 47

3.4.4 Facial Interfaces 48

3.4.5 Other Sleep Apnea Devices 49

3.5 Medication 50

3.5.1 Prescription Drugs 51

3.5.2 OTC Drugs 52

3.5.3 Herbal Drugs 53

3.6 Wearable Devices 54

3.7 Other Product Types 55

4 Segmentation of North America Market by Indication 56

4.1 Market Overview by Indication 56

4.2 Insomnia 58

4.3 Sleep Apnea 59

4.4 Narcolepsy 60

4.5 Restless Leg Syndrome 61

4.6 REM Sleep Behavior Disorder 62

4.7 Sleepwalking 63

4.8 Other Indications 64

5 Segmentation of North America Market by Distribution Channel 65

5.1 Market Overview by Distribution Channel 65

5.2 Drug Stores 67

5.3 E-Commerce 68

5.4 Hospital Pharmacies 69

5.5 Retail Pharmacies 70

6 North America Market 2021-2031 by Country 71

6.1 Overview of North America Market 71

6.2 U.S. 74

6.3 Canada 77

6.4 Mexico 79

7 Competitive Landscape 81

7.1 Overview of Key Vendors 81

7.2 New Product Launch, Partnership, Investment, and M&A 84

7.3 Company Profiles 85

Advanced Brain Monitoring Inc. 85

Apex Medical Corp. 87

Apnea Sciences Corporation 88

BMC Medical Co., Ltd. 89

Braebon Medical Corp. 90

Cadwell Industries Inc. 91

Cleveland Medical Devices Inc. 92

Compumedics Limited 93

Drive DeVilbiss Healthcare Inc. 94

Fisher & Paykel Healthcare Corp. Ltd. 95

GlaxoSmithKline plc 96

Itamer Medical Ltd. 97

Koninklijke Philips N. V. 98

Merck & Co., Inc. 99

Natus Medical Inc. 100

Nihon Kohden Corporation 101

Pfizer Inc. 102

ResMed Inc. 103

Sanofi S. A. 104

Sleep Number Corporation 105

SleepMed Inc. 106

SomnoMed Inc. 107

Teva Pharmaceutical Industries Ltd. 108

RELATED REPORTS 109

 

List of Tables:

 

Table 1.  Snapshot of North America Sleep Aids Market in Balanced Perspective, 2021-2031 17

Table 2. World Economic Outlook, 2021-2031 20

Table 3. World Health Spending by Region, $ bn, 2013-2020 27

Table 4.  Main Product Trends and Market Opportunities in North America Sleep Aids Market 31

Table 5. North America Sleep Aids Market by Product Type, 2021-2031, $ mn 39

Table 6. North America Sleep Aids Market: Sleep Apnea Devices by Type, 2021-2031, $ mn 44

Table 7. North America Sleep Aids Market: Medication by Type, 2021-2031, $ mn 50

Table 8. North America Sleep Aids Market by Indication, 2021-2031, $ mn 56

Table 9. North America Sleep Aids Market by Distribution Channel, 2021-2031, $ mn 65

Table 10. North America Sleep Aids Market by Country, 2021-2031, $ mn 72

Table 11. U.S. Sleep Aids Market by Product Type, 2021-2031, $ mn 76

Table 12. U.S. Sleep Aids Market by Indication, 2021-2031, $ mn 76

Table 13. U.S. Sleep Aids Market by Distribution Channel, 2021-2031, $ mn 76

Table 14. Canada Sleep Aids Market by Product Type, 2021-2031, $ mn 78

Table 15. Canada Sleep Aids Market by Indication, 2021-2031, $ mn 78

Table 16. Canada Sleep Aids Market by Distribution Channel, 2021-2031, $ mn 78

Table 17. Mexico Sleep Aids Market by Product Type, 2021-2031, $ mn 80

Table 18. Mexico Sleep Aids Market by Indication, 2021-2031, $ mn 80

Table 19. Mexico Sleep Aids Market by Distribution Channel, 2021-2031, $ mn 80

Table 20. Advanced Brain Monitoring Inc.: Company Snapshot 85

Table 21. Advanced Brain Monitoring Inc.: Business Segmentation 86

Table 22. Advanced Brain Monitoring Inc.: Product Portfolio 86

 

 

 

 

 

List of Figures:

 

Figure 1. Research Method Flow Chart 11

Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 14

Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 16

Figure 4. North America Sleep Aids Market, 2021-2031, $ mn 18

Figure 5. Impact of COVID-19 on Business 21

Figure 6. Primary Drivers and Impact Factors of North America Sleep Aids Market 23

Figure 7.  Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 26

Figure 8. World Population 65 and Over, % of Total Population, 1950-2060 26

Figure 9. Primary Restraints and Impact Factors of North America Sleep Aids Market 28

Figure 10. Investment Opportunity Analysis 32

Figure 11. Porter’s Fiver Forces Analysis of North America Sleep Aids Market 35

Figure 12. Breakdown of North America Sleep Aids Market by Product Type, 2021-2031, % of Revenue 40

Figure 13. North America Addressable Market Cap in 2022-2031 by Product Type, Value ($ mn) and Share (%) 40

Figure 14. North America Sleep Aids Market by Product Type: Smart Bedding, 2021-2031, $ mn 41

Figure 15. North America Sleep Aids Market by Product Type: Sleep Lab Services, 2021-2031, $ mn 42

Figure 16. North America Sleep Aids Market by Product Type: Sleep Apnea Devices, 2021-2031, $ mn 43

Figure 17. North America Sleep Aids Market by Sleep Apnea Devices: Adaptive Servo-Ventilators (ASVs), 2021-2031, $ mn 45

Figure 18. North America Sleep Aids Market by Sleep Apnea Devices: Positive Airway Pressure (PAP) Devices, 2021-2031, $ mn 46

Figure 19. North America Sleep Aids Market by Sleep Apnea Devices: Oral Appliances, 2021-2031, $ mn 47

Figure 20. North America Sleep Aids Market by Sleep Apnea Devices: Facial Interfaces, 2021-2031, $ mn 48

Figure 21. North America Sleep Aids Market by Sleep Apnea Devices: Other Sleep Apnea Devices, 2021-2031, $ mn 49

Figure 22. North America Sleep Aids Market by Product Type: Medication, 2021-2031, $ mn 50

Figure 23. North America Sleep Aids Market by Medication: Prescription Drugs, 2021-2031, $ mn 51

Figure 24. North America Sleep Aids Market by Medication: OTC Drugs, 2021-2031, $ mn 52

Figure 25. North America Sleep Aids Market by Medication: Herbal Drugs, 2021-2031, $ mn 53

Figure 26. North America Sleep Aids Market by Product Type: Wearable Devices, 2021-2031, $ mn 54

Figure 27. North America Sleep Aids Market by Product Type: Other Product Types, 2021-2031, $ mn 55

Figure 28. Breakdown of North America Sleep Aids Market by Indication, 2021-2031, % of Sales Revenue 57

Figure 29. North America Addressable Market Cap in 2022-2031 by Indication, Value ($ mn) and Share (%) 57

Figure 30. North America Sleep Aids Market by Indication: Insomnia, 2021-2031, $ mn 58

Figure 31. North America Sleep Aids Market by Indication: Sleep Apnea, 2021-2031, $ mn 59

Figure 32. North America Sleep Aids Market by Indication: Narcolepsy, 2021-2031, $ mn 60

Figure 33. North America Sleep Aids Market by Indication: Restless Leg Syndrome, 2021-2031, $ mn 61

Figure 34. North America Sleep Aids Market by Indication: REM Sleep Behavior Disorder, 2021-2031, $ mn 62

Figure 35. North America Sleep Aids Market by Indication: Sleepwalking, 2021-2031, $ mn 63

Figure 36. North America Sleep Aids Market by Indication: Other Indications, 2021-2031, $ mn 64

Figure 37. Breakdown of North America Sleep Aids Market by Distribution Channel, 2021-2031, % of Sales Revenue 66

Figure 38. North America Addressable Market Cap in 2022-2031 by Distribution Channel, Value ($ mn) and Share (%) 66

Figure 39. North America Sleep Aids Market by Distribution Channel: Drug Stores, 2021-2031, $ mn 67

Figure 40. North America Sleep Aids Market by Distribution Channel: E-Commerce, 2021-2031, $ mn 68

Figure 41. North America Sleep Aids Market by Distribution Channel: Hospital Pharmacies, 2021-2031, $ mn 69

Figure 42. North America Sleep Aids Market by Distribution Channel: Retail Pharmacies, 2021-2031, $ mn 70

Figure 43. Breakdown of North America Sleep Aids Market by Country, 2021 and 2031, % of Revenue 72

Figure 44. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 73

Figure 45. U.S. Sleep Aids Market, 2021-2031, $ mn 75

Figure 46. Canada Sleep Aids Market, 2021-2031, $ mn 77

Figure 47.  Sleep Aids Market in Mexico, 2021-2031, $ mn 79

Figure 48. Growth Stage of North America Sleep Aids Industry over the Forecast Period 81